Optometrist · Lexington, KY
NPI
1619910569
Since 2006
Specialty
Optometrist
Code 152W00000X
Group practices
3
Medicare group memberships
Hospitals
0
Hospital affiliations
601 Perimeter Dr, Suite 200
Lexington, KY, 40517
Phone (859) 278-9393
Groups this clinician bills Medicare through
Medicare paid, 2024
$141K
1,468 services
Medicare patients, 2024
198
Average age 74
Drug cost, 2024
$1.3M
685 prescriptions
Company payments, 2025
$594K
From 22 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Paul M Karpecki was code 83861 (clinical chemistry), 575 times for 160 patients. In total Paul M Karpecki billed 1,468 services in 20 codes, and Medicare paid $141K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-11-28.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 83861 Clinical Chemistry | Office | 575 | 160 | $21.96 | $13K |
| 99214 Office E&M - Established | Office | 325 | 157 | $82.34 | $27K |
| 99213 Office E&M - Established | Office | 285 | 122 | $62.07 | $18K |
| 65778 Eye | Office | 102 | 43 | $742.76 | $76K |
| 92002 Ophthalmological E&M | Office | 41 | 41 | $51.37 | $2,106 |
| 92285 Standard X-ray | Office | 37 | 36 | $13.27 | $491 |
| 68761 Eye | Office | 23 | 18 | $131.17 | $3,017 |
| 67820 Eye | Office | 16 | 14 | $9.76 | $156 |
By year: 2022 $80K for 936 services; 2023 $83K for 946 services; 2024 $141K for 1,468 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 83861 Clinical Chemistry | 575 | 160 | $21.96 | $13K |
Medicare prescription drug claims, 2024
In 2024, the drug Paul M Karpecki prescribed most often to Medicare patients was Xdemvy (Lotilaner), with 150 prescriptions and refills. In total Paul M Karpecki wrote 685 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Xdemvy Lotilaner | 150 | 217 | 122 | $282K |
| Miebo Perfluorohexyloctane/Pf | 114 | 118 | 40 | $86K |
| Prednisolone Acetate Generic | 84 | 117 | 71 | $3,358 |
| Xiidra Lifitegrast | 49 | 71 | 12 | $47K |
| Restasis Cyclosporine | 47 | 76 | 13 | $47K |
| Tyrvaya Varenicline Tartrate | 29 | 29 | Under 11 | $18K |
| Fluorometholone Generic | 26 | 32 | 19 | $1,866 |
| Vevye Cyclosporine | 24 | 24 | Under 11 | $20K |
| Cyclosporine Generic | 19 | 19 | Under 11 | $4,068 |
| Flarex Fluorometholone Acetate | 17 | 17 | Under 11 | $2,463 |
| Lotemax Loteprednol Etabonate | 16 | 17 | Under 11 | $5,521 |
| Oxervate Cenegermin-Bkbj | 15 | 15 | Under 11 | $722K |
| Valacyclovir Valacyclovir Hcl | 14 | 20 | Under 11 | $343 |
| Doxycycline Hyclate Generic | 12 | 19 | Under 11 | $882 |
Brand drugs: 604 claims; generic drugs: 81 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Paul M Karpecki $594K ($594K in general payments such as food, travel and fees) from 22 companies. The largest payer was Harrow Eye, LLC with $108K.
| Company | Payments | Amount |
|---|---|---|
| Harrow Eye, LLC | 44 | $108K |
| Mallinckrodt Hospital Products Inc. | 71 | $101K |
| Bausch & Lomb Americas Inc. BLCO | 92 | $95K |
| Tarsus Pharmaceuticals, Inc. TARS | 69 | $70K |
| Oasis Medical, Inc. | 1 | $50K |
| Biotissue Holdings Inc. | 10 | $36K |
| Sight Sciences, Inc. SGHT | 18 | $27K |
| Dompe US, Inc. | 31 | $25K |
| OCULUS, Inc. | 4 | $18K |
| Alcon Vision LLC ALC | 31 | $18K |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.